SPC Logo

RoActemra 20mg/ml Concentrate for Solution for Infusion

Last Updated on eMC 27-Aug-2014 View changes  | Roche Products Limited Contact details

Risk Management

This product has additional materials to minimise the risk during use.   Please register or log in to view the materials.

The following materials are available for healthcare professionals:

RoActemra (tocilizumab) Step by Step Dosing & Administration Guide for HCPs - IV & SC for RA

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan. Please register or log in to view the materials.

RoActemra (tocilizumab) Important Efficacy and Safety Information for HCPs - IV and SC for RA

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan. Please register or log in to view the materials.

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Company contact details

Roche Products Limited

Company image
Address

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW

Fax

+44 (0)1707 338 297

Medical Information e-mail
Medical Information Fax

+44 (0)1707 384555

Telephone

+44 (0)1707 366 000

Medical Information Direct Line

+44 (0)800 328 1629

Customer Care direct line

+44 (0)800 731 5711

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

tocilizumab

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.